149 related articles for article (PubMed ID: 36642184)
41. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.
Lima VV; Giachini FR; Carneiro FS; Carvalho MH; Fortes ZB; Webb RC; Tostes RC
Cardiovasc Res; 2011 Feb; 89(3):614-22. PubMed ID: 20978008
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
[TBL] [Abstract][Full Text] [Related]
43. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
[TBL] [Abstract][Full Text] [Related]
44. Caffeine-induced protein kinase A activation restores cognitive deficits induced by sleep deprivation by regulating
Tran TT; Park J; Kim DY; Han IO
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C978-C989. PubMed ID: 38314722
[TBL] [Abstract][Full Text] [Related]
45. Increased O-GlcNAcylation induces myocardial hypertrophy.
Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
[TBL] [Abstract][Full Text] [Related]
46. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
47. Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy.
Medford HM; Porter K; Marsh SA
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H114-23. PubMed ID: 23624624
[TBL] [Abstract][Full Text] [Related]
48. Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca
Ednie AR; Bennett ES
Basic Res Cardiol; 2020 Sep; 115(6):59. PubMed ID: 32910282
[TBL] [Abstract][Full Text] [Related]
49. Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3.
Zhang J; Yu P; Hua F; Hu Y; Xiao F; Liu Q; Huang D; Deng F; Wei G; Deng W; Ma J; Zhu W; Zhang J; Yu S
Aging (Albany NY); 2020 Nov; 12(24):25452-25468. PubMed ID: 33231560
[TBL] [Abstract][Full Text] [Related]
50. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
[TBL] [Abstract][Full Text] [Related]
51. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
[TBL] [Abstract][Full Text] [Related]
52. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Nagel AK; Ball LE
Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
[TBL] [Abstract][Full Text] [Related]
53. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation.
Cheung WD; Hart GW
J Biol Chem; 2008 May; 283(19):13009-20. PubMed ID: 18353774
[TBL] [Abstract][Full Text] [Related]
54. Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation.
Hu P; Shimoji S; Hart GW
FEBS Lett; 2010 Jun; 584(12):2526-38. PubMed ID: 20417205
[TBL] [Abstract][Full Text] [Related]
55. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
Copeland RJ; Bullen JW; Hart GW
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E17-28. PubMed ID: 18445751
[TBL] [Abstract][Full Text] [Related]
56. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
57. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
58. O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.
Spaner DE
Front Immunol; 2021; 12():772304. PubMed ID: 34868034
[TBL] [Abstract][Full Text] [Related]
59. Regulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans.
Lee J; Kim KY; Lee J; Paik YK
J Biol Chem; 2010 Jan; 285(5):2930-9. PubMed ID: 19940149
[TBL] [Abstract][Full Text] [Related]
60. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
